- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↓ -0.19%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan and its peers as on 21 August, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan | 24.95% | -0.19% | -0.46% | 1.39% | 9.56% | 24.09% | - | - | - | - |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -4.52% | -0.31% | -1.01% | 0.61% | 3.5% | -6.77% | 8.04% | 14.28% | 16.92% | 14.11% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | -1.66% | 0.07% | -0.07% | 0.97% | 5.68% | 1.7% | 11.14% | 10.16% | 14.05% | 12.13% |
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | 23.27% | -0.4% | -0.88% | 1.43% | 9.85% | 19.12% | 24.15% | 19.25% | 26.46% | 15.04% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | 2.72% | -0.03% | -1.43% | -1.99% | 0.11% | 4.99% | 15.77% | 18.42% | 20.37% | 15.3% |
| SBI COMMA Fund - DIRECT PLAN - Growth | 6.52% | -0.2% | -0.21% | 0.6% | 0.22% | 12.28% | 17.88% | 12.65% | 20.63% | 15.66% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | - | - | - | - | - | 52.37% | 1.73% |
Discrete returns (monthly)
| Month | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | 2.16% | 1.22% | -1.38% | -4.65% | 6.99% | -4.36% | 7.84% | 5.11% | 6.59% | 3.59% |
Returns from spefic dates
| Description | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|
| Returns | 17.53% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 99.53% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 0.47% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 9.66% |
| Divis Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 9.14% |
| Max Healthcare Institute Limited | MAXHEALTH (INE027H01010) | Healthcare Services | 4.82% |
| Aster DM Quality Care Limited | ASTERDM (INE914M01019) | Healthcare Services | 4.70% |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 4.67% |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 4.64% |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 3.67% |
| Acutaas Chemicals Limited | ACUTAAS (INE00FF01025) | Pharmaceuticals & Biotechnology | 3.58% |
| Anthem Biosciences Limited | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 3.56% |
| Neuland Laboratories Limited | NEULANDLAB (INE794A01010) | Pharmaceuticals & Biotechnology | 3.40% |
| Ipca Laboratories Ltd. | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 3.22% |
| Global Health Limited | MEDANTA (INE474Q01031) | Healthcare Services | 3.05% |
| Fortis Healthcare Limited | FORTIS (INE061F01013) | Healthcare Services | 2.79% |
| Krishna Institute Of Medical Sciences Limited | KIMS (INE967H01025) | Healthcare Services | 2.70% |
| Glenmark Pharmaceuticals Ltd. | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 2.59% |
| Jupiter Life Line Hospitals Limited | (INE682M01020) | Healthcare Services | 2.45% |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 2.28% |
| Shilpa Medicare Ltd | SHILPAMED (INE790G01031) | Pharmaceuticals & Biotechnology | 2.25% |
| Vijaya Diagnostic Centre Limited | VIJAYA (INE043W01024) | Healthcare Services | 2.23% |
| Metropolis Healthcare Ltd. | METROPOLIS (INE112L01020) | Healthcare Services | 2.14% |
| Zydus Lifesciences Limited | ZYDUSLIFE (INE010B01027) | Pharmaceuticals & Biotechnology | 2.10% |
| Biocon Ltd. | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 2.01% |
| Dr Reddys Laboratories Ltd. | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 1.92% |
| Wockhardt Ltd. | WOCKPHARMA (INE049B01025) | Pharmaceuticals & Biotechnology | 1.89% |
| Sai Life Sciences Limited | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 1.62% |
| Rubicon Research Limited | RUBICON (INE506V01022) | Pharmaceuticals & Biotechnology | 1.61% |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 1.58% |
| Thyrocare Technologies Ltd. | THYROCARE (INE594H01019) | Healthcare Services | 1.42% |
| Ajanta Pharma Limited | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 1.28% |
| Eris Lifesciences Ltd | ERIS (INE406M01024) | Pharmaceuticals & Biotechnology | 1.25% |
| CORONA REMEDIES LIMITED | CORONA (INE02ZQ01018) | Pharmaceuticals & Biotechnology | 1.24% |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 1.07% |
| Jubilant Pharmova Limited | JUBLPHARMA (INE700A01033) | Pharmaceuticals & Biotechnology | 1.01% |
| BAJAJ HEALTHCARE LIMITED | BAJAJHCARE (INE411U01027) | Pharmaceuticals & Biotechnology | 0.65% |
| Novartis India Ltd. | NOVARTIND (INE234A01025) | Pharmaceuticals & Biotechnology | 0.51% |
| Laxmi Dental Limited | LAXMIDENTL (INE0WO601020) | Healthcare Equipment & Supplies | 0.47% |
| Cohance Lifesciences Limited | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 0.36% |
Portfolio data is as on date 31 July, 2026
NAV history
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 21 August, 2026 | 22.058 | -0.19% |
| 20 August, 2026 | 22.099 | -0.05% |
| 19 August, 2026 | 22.111 | -0.85% |
| 18 August, 2026 | 22.3 | 0.43% |
| 17 August, 2026 | 22.204 | 0.2% |
| 14 August, 2026 | 22.159 | -0.03% |
| 13 August, 2026 | 22.166 | -0.06% |
| 12 August, 2026 | 22.179 | -0.87% |
| 11 August, 2026 | 22.373 | 0.69% |
| 10 August, 2026 | 22.22 | 0.14% |
| 7 August, 2026 | 22.19 | 0.48% |
| 6 August, 2026 | 22.085 | 0.18% |
| 5 August, 2026 | 22.046 | 0.52% |
| 4 August, 2026 | 21.933 | -0.27% |
| 3 August, 2026 | 21.992 | 0.93% |
| 31 July, 2026 | 21.79 | 0.08% |
| 30 July, 2026 | 21.772 | -0.3% |
| 29 July, 2026 | 21.838 | 1.37% |
| 28 July, 2026 | 21.543 | -0.11% |
| 27 July, 2026 | 21.566 | 1.47% |
| 24 July, 2026 | 21.253 | -0.22% |
| 23 July, 2026 | 21.3 | -0.68% |
| 22 July, 2026 | 21.446 | -1.42% |
| 21 July, 2026 | 21.755 | 0.17% |
| 20 July, 2026 | 21.718 | 0.97% |
| 17 July, 2026 | 21.51 | -0.87% |
| 16 July, 2026 | 21.699 | 0.14% |
| 15 July, 2026 | 21.669 | 0.83% |
| 14 July, 2026 | 21.49 | 0.6% |
| 13 July, 2026 | 21.361 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
The latest NAV of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is 22.058 as on 21 August, 2026.What are YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
The YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 24.95% as on 21 August, 2026.What are 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
The 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 24.09% as on 21 August, 2026.